Improving inpatient pharmacoterapeutic process by Lean Six Sigma methodology

[EN] Background Lean Six Sigma methodology has been used to improve care processes, eliminate waste, reduce costs, and increase patient satisfaction. Objective To analyse the results obtained with Lean Six Sigma methodology in the diagnosis and improvement of the inpatient pharmacotherapy process during structural and organisational changes in a tertiary hospital. Material and methods Scope: 1.000 beds tertiary hospital. Design prospective observational study. The define, measure, analyse, improve and control (DMAIC), were deployed from March to September 2011. An Initial Project Charter was updated as results were obtained. Population and sample: 131 patients with treatments prescribed within 24 h after admission and with 4 drugs. Variables: safety indicators (medication errors), and efficiency indicators (complaints and time delays). Results Proportion of patients with a medication error was reduced from 61.0% (25/41 patients) to 55.7% (39/70 patients) in four months. Percentage of errors (regarding the opportunities for error) decreased in the different phases of the process: Prescription: from 5.1% (19/372 opportunities) to 3.3% (19/572 opportunities); Preparation: from 2.7% (14/525 opportunities) to 1.3% (11/847 opportunities); and administration: from 4.9% (16/329 opportunities) to 3.0% (13/433 opportunities). Nursing complaints decreased from 10.0% (2119/21038 patients) to 5.7% (1779/31097 patients). The estimated economic impact was 76,800 euros saved. Conclusions An improvement in the pharmacotherapeutic process and a positive economic impact was observed, as well as enhancing patient safety and efficiency of the organization. Standardisation and professional training are future Lean Six Sigma candidate projects.[ES] Introducción La metodología Lean Seis Sigma se utilizó para mejorar procesos, eliminar desperdicios, reducir costes y aumentar la satisfacción de clientes. Objetivo Analizar los resultados obtenidos con la metodología Lean Seis Sigma en el diagnóstico y la mejora del proceso farmacoterapéutico del paciente hospitalizado durante el cambio estructural y organizativo de un hospital terciario. Material y métodos Ámbito: hospital general terciario con 1.000 camas. Diseño del estudio: observacional y prospectivo. Se desplegaron las etapas definir, medir, analizar, mejorar y controlar (DMAIC) entre marzo y septiembre de 2011, actualizando el Project Charter inicial según resultados. Población y muestra: 131 pacientes hospitalizados con tratamientos prescritos en las 24 h siguientes al ingreso y con 4 medicamentos. Variables: indicadores de seguridad (errores de medicación) y de eficiencia (tiempos de demora y reclamaciones). Resultados La proporción de pacientes con algún error de medicación se redujo del 61,0 (25/41 pacientes) al 55,7% (39/70 pacientes) en 4 meses. Los porcentajes de errores, con respecto a las oportunidades de error, en distintas fases del proceso disminuyeron: prescripción 5,1 (19/372) a 3,3% (19/572); preparación 2,7 (14/525) a 1,3% (11/847 oportunidades); y administración: 4,9 (16/329) a 3,0% (13/433). Las reclamaciones se redujeron del 10,0 (2.119/21.038 pacientes) a 5,7% (1.779/31.097 pacientes). El impacto económico se estimó en 76.800 euros evitados. Conclusiones Se observó una mejora del proceso farmacoterapéutico y un impacto financiero positivo que ha repercutido en la seguridad del paciente y la eficiencia de la organización. La normalización y la formación de profesionales podrían ser proyectos futuros de Lean Seis Sigma.Font Noguera, I.; Fernández Megía, M.; Ferrer, A.; Balasch Parisi, S.; Edo Solsona, M.; Poveda Andres, J. (2013). Mejora del proceso farmacoterapéutico del paciente hospitalizado mediante la metodología Lean Seis Sigma. Revista de Calidad Asistencial. 28(6):370-380. doi:10.1016/j.cali.2013.04.003S37038028

Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart

AIMS : The glucose-driven enzymatic modification of myocardial proteins by the sugar moiety, β-N-acetylglucosamine (O-GlcNAc), is increased in pre-clinical models of diabetes, implicating protein O-GlcNAc modification in diabetes-induced heart failure. Our aim was to specifically examine cardiac manipulation of the two regulatory enzymes of this process on the cardiac phenotype, in the presence and absence of diabetes, utilising cardiac-targeted recombinant-adeno-associated viral-vector-6 (rAAV6)-mediated gene delivery. METHODS AND RESULTS : In human myocardium, total protein O-GlcNAc modification was elevated in diabetic relative to non-diabetic patients, and correlated with left ventricular (LV) dysfunction. The impact of rAAV6-delivered O-GlcNAc transferase (rAAV6-OGT, facilitating protein O-GlcNAcylation), O-GlcNAcase (rAAV6-OGA, facilitating de-O-GlcNAcylation), and empty vector (null) were determined in non-diabetic and diabetic mice. In non-diabetic mice, rAAV6-OGT was sufficient to impair LV diastolic function and induce maladaptive cardiac remodelling, including cardiac fibrosis and increased Myh-7 and Nppa pro-hypertrophic gene expression, recapitulating characteristics of diabetic cardiomyopathy. In contrast, rAAV6-OGA (but not rAAV6-OGT) rescued LV diastolic function and adverse cardiac remodelling in diabetic mice. Molecular insights implicated impaired cardiac PI3K(p110α)-Akt signalling as a potential contributing mechanism to the detrimental consequences of rAAV6-OGT in vivo. In contrast, rAAV6-OGA preserved PI3K(p110α)-Akt signalling in diabetic mouse myocardium in vivo and prevented high glucose-induced impairments in mitochondrial respiration in human cardiomyocytes in vitro. CONCLUSION: Maladaptive protein O-GlcNAc modification is evident in human diabetic myocardium, and is a critical regulator of the diabetic heart phenotype. Selective targeting of cardiac protein O-GlcNAcylation to restore physiological O-GlcNAc balance may represent a novel therapeutic approach for diabetes-induced heart failure.Darnel Prakoso, Shiang Y Lim, Jeffrey R Erickson, Rachel S Wallace, Jarmon G Lees, Mitchel Tate ... et al

The Effect of Minimum Nurse Staffing Legislation on Uncompensated Care Provided by California Hospitals

This study assesses whether California’s minimum nurse staffing legislation affected the amount of uncompensated care provided by California hospitals. Using data from California’s Office of Statewide Health Planning and Development, the American Hospital Association Annual Survey and InterStudy, we divide hospitals into quartiles based on pre-regulation staffing levels. Controlling for other factors, we estimate changes in the growth rate of uncompensated care in the three lowest staffing quartiles relative to the quartile of hospitals with the highest staffing level. Our sample includes short-term general hospitals over the period 1999 to 2006. We find that growth rates in uncompensated care are lower in the first three staffing quartiles as compared to the highest quartile; however, results are statistically significant only for county and for-profit hospitals in quartiles one and three. We conclude that minimum nurse staffing ratios may lead some hospitals to limit uncompensated care, likely due to increased financial pressure